Lamotrigin Aristo (Lamotrigine)

Lamotrigine works by blocking voltage‑gated sodium channels on neurons, which stabilises the neuronal membrane and reduces the release of excitatory neurotransmitters such as glutamate. This action diminishes excessive neuronal firing that contributes to seizures, mood swings, and migraine development.

The appropriate dose of Lamotrigin Aristo is determined individually by a qualified prescriber based on the patient’s condition, age, renal function, and concomitant medications. Dosage titration is typically gradual to minimise the risk of skin reactions.

The safety of lamotrigine in pregnancy and lactation is not fully established. It is classified as pregnancy category unknown, and clinicians weigh potential benefits against risks. Women who are pregnant, planning pregnancy, or breastfeeding should discuss treatment options with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lamotrigine differs from many antiepileptics by its broad spectrum of activity and relatively favourable cognitive profile. Unlike enzyme‑inducing agents such as carbamazepine, it has a lower potential for drug‑induced liver enzyme elevation, but it requires careful monitoring for rare but serious skin reactions.

Lamotrigin Aristo should be stored at room temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Lamotrigin Aristo is taken orally, usually with or without food, as directed by the prescribing clinician. Tablets should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed.

The most serious risks include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, blood dyscrasias, hepatic failure, and the emergence of suicidal thoughts or behaviours. Prompt medical attention is required if any of these symptoms appear.

Lamotrigin Aristo is contraindicated in individuals with a known hypersensitivity to lamotrigine or any of its excipients. Patients with a history of severe skin reactions to antiepileptic drugs should avoid its use, and it should be prescribed with caution in those with cardiac conduction abnormalities.